Advertisement
Screener

aTYR PHARMA INC (ATYR) EBITDA

aTYR PHARMA INC (ATYR) EBITDA

  • 2026-06-30: Basis Reported; EBITDA -$10.71M*; Operating income -$10.88M; Depreciation and amortization $168.00K*.
  • 2026-03-31: Basis Reported; EBITDA -$11.27M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA -$14.63M; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA -$26.58M*; Operating income -$26.75M; Depreciation and amortization $165.00K*.

Complete source-backed ebitda history.

Available history
2013-12-31 to 2026-03-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported-$10.71M*-$10.88M$168.00K*(m)(m)$73.00K*-$9.35M*(m)$6.75M(m)(m)
2026-03-31Reported-$11.27M(m)(m)(m)(m)$138.00K-$12.52M(m)$7.32M(m)(m)
2025-12-31Reported-$14.63M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2025-09-30Reported-$26.58M*-$26.75M$165.00K*$190.00K-13989.47%*$37.00K*-$20.48M*(m)$22.13M(m)(m)
2025-06-30Reported-$20.15M*-$20.31M$166.00K*$0.00(m)$9.00K*-$13.89M*(m)$15.38M(m)(m)
2025-03-31Reported-$15.61M(m)(m)(m)(m)$0.00-$15.42M(m)$11.81M(m)(m)
2024-12-31Reported-$15.65M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2024-09-30Reported-$17.96M*-$18.14M$178.00K*$0.00(m)$15.00K*-$13.16M*(m)$14.81M(m)(m)
2024-06-30Reported-$17.14M*-$17.32M$177.00K*$0.00(m)$8.00K*-$20.45M*(m)$13.97M(m)(m)
2024-03-31Reported-$16.46M(m)(m)(m)-7003.40%$17.00K-$22.38M(m)$13.36M(m)(m)
2023-12-31Reported-$15.78M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2023-09-30Reported-$12.44M*-$12.62M$176.00K*$353.00K-3523.80%*$557.00K*-$9.56M*(m)$10.32M(m)(m)
2023-06-30Reported-$13.40M*-$13.56M$161.00K*$0.00(m)$2.40M*-$12.01M*(m)$9.84M(m)(m)
2023-03-31Reported-$12.71M(m)(m)(m)(m)$1.25M-$590.00K(m)$9.38M(m)(m)
2022-12-31Reported-$7.91M(m)(m)(m)-76.17%(m)(m)(m)(m)(m)(m)
2022-09-30Reported-$13.44M*-$13.49M$49.00K*$0.00(m)$426.00K*-$12.28M*(m)$9.87M(m)(m)
2022-06-30Reported-$12.52M*-$12.58M$63.00K*(m)(m)$53.00K*-$9.12M*(m)$9.13M(m)(m)
2022-03-31Reported-$12.3M(m)(m)(m)(m)$43.00K-$10.12M(m)$8.90M(m)(m)
2021-12-31Reported-$8.53M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-09-30Reported-$7.61M*-$7.73M$123.00K*(m)(m)$61.00K*-$11.47M*(m)$5.14M(m)(m)
2021-06-30Reported-$10.32M*-$10.45M$123.00K*(m)(m)$96.00K*-$7.69M*(m)$7.66M(m)(m)
2021-03-31Reported-$7.08M(m)(m)(m)(m)$17.00K-$5.83M(m)$4.52M(m)(m)
2020-12-31Reported-$4.81M(m)(m)(m)-234.39%(m)(m)(m)(m)(m)(m)
2020-09-30Reported-$6.38M*-$6.51M$128.00K*$148.00K-4313.51%*$12.00K*-$5.55M*(m)$4.62M(m)(m)
2020-06-30Reported-$6.16M*-$6.32M$156.00K*$189.00K-3260.32%*$19.00K*-$6.40M*(m)$4.36M(m)(m)
2020-03-31Reported$2.02M(m)(m)(m)25.00%$166.00K$2.06M(m)$3.62M(m)(m)
2019-12-31Reported-$5.81M(m)(m)(m)-4031.25%(m)(m)(m)(m)(m)(m)
2019-09-30Reported-$5.34M*-$5.50M$154.00K*$184.00K-2904.35%*$28.00K*-$4.25M*(m)$3.80M(m)(m)
2019-06-30Reported-$5.48M*-$5.64M$157.00K*$94.00K-5834.04%*$0.00*-$4.82M*(m)$3.31M(m)(m)
2019-03-31Reported-$5.71M(m)(m)(m)(m)$10.00K-$6.02M(m)$3.35M(m)(m)
2018-12-31Reported-$5.78M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2018-09-30Reported-$6.49M*-$6.68M$191.00K*(m)(m)$36.00K*-$6.46M*(m)$4.20M(m)(m)
2018-06-30Reported-$9.77M*-$9.96M$192.00K*(m)(m)$51.00K*-$9.19M*(m)$6.48M(m)(m)
2018-03-31Reported-$10.04M(m)(m)(m)(m)$498.00K-$10.58M(m)$6.15M(m)(m)
2017-12-31Reported-$11.04M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2017-09-30Reported-$10.68M*-$10.83M$152.00K*(m)(m)$441.00K*-$8.89M*(m)$7.13M(m)(m)
2017-06-30Reported-$11.73M*-$11.91M$174.00K*(m)(m)$449.00K*(m)(m)$8.42M(m)(m)
2017-03-31Reported-$12.99M(m)(m)(m)(m)$262.00K(m)(m)$9.20M(m)(m)
2016-12-31Reported-$12.31M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2016-09-30Reported-$13.64M*-$13.87M$222.00K*(m)(m)$64.00K*(m)(m)$10.39M(m)(m)
2016-06-30Reported-$15.21M*-$15.43M$224.00K*(m)(m)$176.00K*(m)(m)$11.31M(m)(m)
2016-03-31Reported-$15.88M(m)(m)(m)(m)$314.00K(m)(m)$12.00M(m)(m)
2015-12-31Reported-$16.26M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2015-09-30Reported-$11.09M*-$11.31M$224.00K*(m)(m)$382.00K*(m)(m)$7.74M(m)(m)
2015-06-30Reported-$10.69M*-$10.90M$210.00K*(m)(m)$40.00K*(m)(m)$7.50M(m)(m)
2015-03-31Reported-$8.71M(m)(m)(m)(m)$123.00K(m)(m)$6.59M(m)(m)
2014-12-31Reported-$5.82M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2014-09-30Reported-$6.02M*-$6.23M$209.00K*(m)(m)$0.00*(m)(m)$4.41M(m)(m)
2014-06-30Reported-$5.16M*-$5.36M$208.00K*(m)(m)$38.00K*(m)(m)$3.64M(m)(m)
2014-03-31Reported-$5.73M(m)(m)(m)(m)$211.00K(m)(m)$4.39M(m)(m)

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported-$76.96M(m)(m)(m)-40506.84%$77.00K-$61.99M(m)$60.22M(m)$0.00
2024-12-31Reported-$67.21M(m)(m)(m)-28598.30%$65.00K-$69.12M(m)$54.37M(m)$0.00
2023-12-31Reported-$54.33M(m)(m)(m)-15390.08%$4.21M-$33.22M(m)$42.29M(m)$0.00
2022-12-31Reported-$46.17M(m)(m)(m)-444.56%$1.64M-$41.89M(m)$42.81M(m)$0.00
2021-12-31Reported-$33.54M(m)(m)(m)(m)$192.00K-$33.08M(m)$23.26M(m)$0.00
2020-12-31Reported-$15.34M(m)(m)(m)-146.74%$202.00K-$15.30M(m)$17.29M(m)$0.00
2019-12-31Reported-$22.34M(m)(m)(m)-5294.55%$79.00K-$20.01M(m)$14.05M(m)$0.00
2018-12-31Reported-$32.07M(m)(m)(m)(m)$594.00K-$31.06M(m)$20.39M(m)$0.00
2017-12-31Reported-$46.43M(m)(m)(m)(m)$1.31M-$42.36M(m)$30.07M(m)(m)
2016-12-31Reported-$57.04M(m)(m)(m)(m)$600.00K-$52.86M(m)$42.85M(m)-$49.00K
2015-12-31Reported-$46.75M(m)(m)(m)(m)$664.00K(m)(m)$34.50M(m)(m)
2014-12-31Reported-$22.73M(m)(m)(m)(m)$249.00K(m)(m)$16.78M(m)(m)
2013-12-31Reported-$18.83M(m)(m)(m)(m)$644.00K(m)(m)$13.83M(m)(m)

Similar stocks

Stock NameCountryMarket CapPE Ratio
Quince Therapeutics, Inc. (QNCX)United States$0.031B
CEL SCI CORP (CVM)United States$0.030B-0.81
Scilex Holding Co (SCLX)United States$0.042B-0.14
Metagenomi Therapeutics, Inc. (MGX)United States$0.044B-0.48
Estrella Immunopharma, Inc. (ESLA)United States$0.020B
LeonaBio, Inc. (LONA)United States$0.047B-0.61
Jasper Therapeutics, Inc. (JSPR)United States$0.020B-0.37
Instil Bio, Inc. (TIL)United States$0.048B-1.73
Tevogen Inc. (TVGN)United States$0.049B
BioCardia, Inc. (BCDA)United States$0.016B